Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    11th Day of Christmas: Medable predicts agentic AI will reshape clinical trials and regulation in 2026

    On the 11th Day of Christmas in Discover Pharma’s industry [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Oushk recognised among first to meet new GPhC standards for supplying weight-loss medicines

    The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Age-related macular degeneration market across 7MM forecast to reach $20.5 billion by 2034

    The age-related macular degeneration market across the seven major markets [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Confo therapeutics nominates SSTR5 agonist antibody CFTX-2034 for post-bariatric hypoglycemia

    Confo Therapeutics has selected CFTX-2034, an SSTR5 agonist antibody, as [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    NICE recommends amivantamab and lazertinib as first-line option for EGFR-mutated lung cancer

      The National Institute for Health and Care Excellence has [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PHARMASEAL: five gold rings that shaped clinical operations in 2025

    Like the five gold rings in the Christmas carol, 2025 [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Nanexa and Moderna sign licence and option agreement for Pharmashell drug delivery development

    Nanexa has entered into a licence and option agreement with [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    ICON 2025 global biotech survey shows China leading innovation and highlights Western opportunities

    ICON plc has released findings from its 2025 global biotech [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Today Discover Pharma launches its annual 12 Days of Christmas campaign featuring CluePoints insight on RBQM

    The launch of the 12 Days of Christmas campaign marks [...]

    May 5, 2026
Previous373839Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Aurora Cannabis acquires UK medical cannabis importer and pharmacy
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Dunbar Pharma brings plant-derived dronabinol API to UK through IPS Pharma
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Qureight expands London operations to develop AI chest imaging model
    Categories: Digital & Data
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top